EPO Patents = 3

Forward Citations = 10

Loading Chart...

22 inventors (with patents filed for the assignee):

Ian Peter Holmes (7 out of 7 patents)

Richard Charles Foitzik (7 out of 12 patents)

Gillian Elizabeth Lunniss (6 out of 6 patents)

4. Catherine Fae Hemley (6 out of 6 patents)

5. Danny Ganame (6 out of 7 patents)

6. Romina Lessene (6 out of 7 patents)

7. Scott Raymond Walker (5 out of 14 patents)

8. Neil Choi (4 out of 4 patents)

9. Michelle Ang Camerino (3 out of 16 patents)

10. Ylva Elisabet Bergman (3 out of 7 patents)

11. Wilhelmus Johannes Antonius Kersten (3 out of 4 patents)

12. Marica Nikac (3 out of 3 patents)

13. Paul Anthony Stupple (3 out of 32 patents)

14. Andrew John Harvey (2 out of 23 patents)

15. Yiva Bergman (2 out of 2 patents)

7 patents: Sort by Forward Citations

1. 9856252 - 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase (2018-01-02),

2. 9421205 - FAK inhibitors (2016-08-23),

3. 9266864 - VEGFR3 inhibitors (2016-02-23),

4. 9238644 - VEGFR3 inhibitors (2016-01-19),

5. 9174946 - Selective FAK inhibitors (2015-11-03),

6. 9120761 - Selective FAK inhibitors (2015-09-01),

7. 9012461 - FAK inhibitors (2015-04-21),

Cancer Therapeutics CRC Pty Limited is a leading biotechnology company focused on developing novel and innovative cancer therapies. With a strong emphasis on research and development, the company is dedicated to improving patient outcomes and advancing the field of cancer treatment. Through strategic partnerships and collaborations, Cancer Therapeutics CRC is at the forefront of cutting-edge research in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

7 Patents

#1 in Bundoora, Victoria

#538 in Australia

Bundoora, Victoria, Australia

Cancer Therapeutics Crc Pty Limited